Relationship Between CT- Value With Prognosis in COVID-19 Patients
1 other identifier
observational
60
1 country
2
Brief Summary
evaluate the relationship between cycle threshold number with final prognosis in COVID-19 patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2021
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2021
CompletedFirst Submitted
Initial submission to the registry
May 25, 2021
CompletedFirst Posted
Study publicly available on registry
May 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2022
CompletedJuly 18, 2023
July 1, 2023
11 months
May 25, 2021
July 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
prognosis
death or alive
6 months
Interventions
cycle threshold number
Eligibility Criteria
COVID-19 PCR Positive
You may qualify if:
- COVID-19 PCR positive
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
SBMU
Tehran, 1666664321, Iran
Nooshin Dalili
Tehran, Iran
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant Professor of SBMU
Study Record Dates
First Submitted
May 25, 2021
First Posted
May 26, 2021
Study Start
February 1, 2021
Primary Completion
January 1, 2022
Study Completion
February 1, 2022
Last Updated
July 18, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share